Burkitt's Lymphoma: Clinical Trials

1 trial for Burkitt's Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Burkitt's Lymphoma: new trials by email Literature Review of Burkitt's Lymphoma trials Research Report on Burkitt's Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Double Cord Versus Haploidentical (BMT CTN 1101)
Haploidentical Bone Marrow Transplant, Double Umbilical Cord Blood Transplant - Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia
Phase 3CompletedMedical College of Wisconsin3682012-06-012021-12-01

Narrower conditions

Burkitt Lymphoma (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

DNA Virus Infections (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

Medical College of Wisconsin (1)

Countries

United States (1)

Top investigators

Mary Horowitz, MD, MS (1)

Results publications

PMID 33475736, PMID 34273598, PMID 37088401, PMID 37120135, PMID 39846144, PMID 41350757

NIH funding

U10HL069294 (1), U24CA076518 (1)